Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Blood Sample Analysis Mycoplasma And Chlamydia Antibodies

Research Leaders

7 sponsors active, led by United States Department of Defense

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Completed3

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT06260371CompletedPrimary

National Observatory of Mycoplasma Infections in Children Under 18 Ages in France

NCT00007735Phase 3Completed

Antibiotic Treatment of Gulf War Veterans' Illnesses

NCT00561028Completed

Chlamydia and Mycoplasma in Coronary Artery Disease

Showing all 3 trials

Research Network

Common Treatments

  • Blood Sample Analysis Mycoplasma And Chlamydia Antibodies1
  • Doxycycline 200mgday Or Placebo1

Active Sponsors

  • United States Department of Defense1
  • University of Sao Paulo1
  • Association Clinique Thérapeutique Infantile du val de Marne1
  • US Department of Veterans Affairs1
  • Groupe de Pathologies Infectieuses Pédiatriques (GPIP)1

Top Investigators

Related Conditions

  • Chlamydia Infections1
  • Persian Gulf Syndrome1
  • Coronary Artery Disease1
  • Atherosclerosis1
  • Hospitalized Children1

Activity Timeline